Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Parsimonious Charge Deconvolution for Native Mass Spectrometry.

Bern M, Caval T, Kil YJ, Tang W, Becker C, Carlson E, Kletter D, Sen KI, Galy N, Hagemans D, Franc V, Heck AJR.

J Proteome Res. 2018 Mar 2;17(3):1216-1226. doi: 10.1021/acs.jproteome.7b00839. Epub 2018 Feb 8.

2.

Characterizing Protein Glycosylation through On-Chip Glycan Modification and Probing.

Reatini BS, Ensink E, Liau B, Sinha JY, Powers TW, Partyka K, Bern M, Brand RE, Rudd PM, Kletter D, Drake R, Haab BB.

Anal Chem. 2016 Dec 6;88(23):11584-11592. Epub 2016 Nov 15.

3.

Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9.

Tang H, Partyka K, Hsueh P, Sinha JY, Kletter D, Zeh H, Huang Y, Brand RE, Haab BB.

Cell Mol Gastroenterol Hepatol. 2016 Feb 1;2(2):201-221.e15.

4.

Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.

Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, Srivastava S, Frazier ML, Sen S, Hollingsworth MA, Rinaudo JA, Killary AM, Brand RE.

PLoS One. 2015 Oct 2;10(10):e0139049. doi: 10.1371/journal.pone.0139049. eCollection 2015.

5.

Benchmark study of automatic annotation of MALDI-TOF N-glycan profiles.

Brito AE, Kletter D, Singhal M, Bern M.

J Proteomics. 2015 Nov 3;129:71-77. doi: 10.1016/j.jprot.2015.05.028. Epub 2015 Jun 3.

6.

Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectins.

Singh S, Pal K, Yadav J, Tang H, Partyka K, Kletter D, Hsueh P, Ensink E, Kc B, Hostetter G, Xu HE, Bern M, Smith DF, Mehta AS, Brand R, Melcher K, Haab BB.

J Proteome Res. 2015 Jun 5;14(6):2594-605. doi: 10.1021/acs.jproteome.5b00142. Epub 2015 May 12.

7.

Exploring the specificities of glycan-binding proteins using glycan array data and the GlycoSearch software.

Kletter D, Curnutte B, Maupin KA, Bern M, Haab BB.

Methods Mol Biol. 2015;1273:203-14. doi: 10.1007/978-1-4939-2343-4_15.

8.

Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.

Tang H, Singh S, Partyka K, Kletter D, Hsueh P, Yadav J, Ensink E, Bern M, Hostetter G, Hartman D, Huang Y, Brand RE, Haab BB.

Mol Cell Proteomics. 2015 May;14(5):1323-33. doi: 10.1074/mcp.M114.047837. Epub 2015 Mar 2.

9.

The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.

Tang H, Hsueh P, Kletter D, Bern M, Haab B.

Adv Cancer Res. 2015;126:167-202. doi: 10.1016/bs.acr.2014.11.003. Epub 2015 Feb 7. Review.

10.

Prediction of glycan motifs using quantitative analysis of multi-lectin binding: Motifs on MUC1 produced by cultured pancreatic cancer cells.

McCarter C, Kletter D, Tang H, Partyka K, Ma Y, Singh S, Yadav J, Bern M, Haab BB.

Proteomics Clin Appl. 2013 Oct;7(9-10):632-41. doi: 10.1002/prca.201300069. Epub 2013 Sep 13.

11.

Determining lectin specificity from glycan array data using motif segregation and GlycoSearch software.

Kletter D, Cao Z, Bern M, Haab B.

Curr Protoc Chem Biol. 2013;5(2):157-69. doi: 10.1002/9780470559277.ch130028.

12.

Global comparisons of lectin-glycan interactions using a database of analyzed glycan array data.

Kletter D, Singh S, Bern M, Haab BB.

Mol Cell Proteomics. 2013 Apr;12(4):1026-35. doi: 10.1074/mcp.M112.026641. Epub 2013 Feb 11.

13.

Intravenous infusions of heparin and penicillins.

Jacobs J, Kletter D, Superstine E, Hill KR, Lynn B, Webb RA.

J Clin Pathol. 1973 Oct;26(10):742-6.

Supplemental Content

Loading ...
Support Center